These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32503473)

  • 1. The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.
    Park KS; Ganesh AB; Berry NT; Mobley YP; Karper WB; Labban JD; Wahlheim CN; Williams TM; Wideman L; Etnier JL
    BMC Neurol; 2020 Jun; 20(1):231. PubMed ID: 32503473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
    Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
    Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning.
    Stojanovic M; Jin Y; Fagan AM; Benzinger TL; Hassenstab J; Cruchaga C; Morris JC; Head D
    Alzheimer Dis Assoc Disord; 2020; 34(3):212-219. PubMed ID: 32520736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial.
    Yu F; Lin FV; Salisbury DL; Shah KN; Chow L; Vock D; Nelson NW; Porsteinsson AP; Jack C
    Trials; 2018 Dec; 19(1):700. PubMed ID: 30577848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly.
    Luck T; Then FS; Luppa M; Schroeter ML; Arélin K; Burkhardt R; Thiery J; Löffler M; Villringer A; Riedel-Heller SG
    Neuropsychology; 2015 May; 29(3):382-387. PubMed ID: 25365563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).
    Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F
    Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Activity, APOE Genotype, and Cognitive Decline: Exploring Gene-Environment Interactions in the UK Biobank.
    Folley S; Zhou A; Llewellyn DJ; Hyppönen E
    J Alzheimers Dis; 2019; 71(3):741-750. PubMed ID: 31450492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.
    Johnson SC; Schmitz TW; Trivedi MA; Ries ML; Torgerson BM; Carlsson CM; Asthana S; Hermann BP; Sager MA
    J Neurosci; 2006 May; 26(22):6069-76. PubMed ID: 16738250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.
    Durazzo TC; Mattsson N; Weiner MW;
    Nicotine Tob Res; 2016 Feb; 18(2):204-11. PubMed ID: 25847292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Physical Activity and Alzheimer's Disease (PAAD) Study: Cognitive outcomes.
    Etnier JL; Karper WB; Labban JD; Piepmeier AT; Shih CH; Dudley WN; Henrich VC; Wideman L
    Ann Behav Med; 2018 Feb; 52(2):175-185. PubMed ID: 29538632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of family history for Alzheimer biomarker abnormalities in the adult children study.
    Xiong C; Roe CM; Buckles V; Fagan A; Holtzman D; Balota D; Duchek J; Storandt M; Mintun M; Grant E; Snyder AZ; Head D; Benzinger TL; Mettenburg J; Csernansky J; Morris JC
    Arch Neurol; 2011 Oct; 68(10):1313-9. PubMed ID: 21987546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.
    Okonkwo OC; Xu G; Dowling NM; Bendlin BB; Larue A; Hermann BP; Koscik R; Jonaitis E; Rowley HA; Carlsson CM; Asthana S; Sager MA; Johnson SC
    Neurology; 2012 May; 78(22):1769-76. PubMed ID: 22592366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study.
    Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA
    J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Exercise Effect on Neurocognitive Function Among Cognitively Normal Late-Middle-Aged Adults With/Without Genetic Risk of AD: The Moderating Role of Exercise Volume and APOE Genotype.
    Chang YK; Etnier JL; Li RH; Ren FF; Ai JY; Chu CH
    J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37526237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
    Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
    Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.